Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 18, Pages 4282
Publisher
MDPI AG
Online
2020-09-18
DOI
10.3390/molecules25184282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer
- (2019) Puvanesswaray Ramakrishnan et al. Acta Pharmaceutica Sinica B
- Synergy of Ginkgetin and Resveratrol in Suppressing VEGF-Induced Angiogenesis: A Therapy in Treating Colorectal Cancer
- (2019) Hu et al. Cancers
- TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors
- (2018) Sumit Mukherjee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells
- (2018) Wei He et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Resveratrol induced reactive oxygen species and endoplasmic reticulum stress‑mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line
- (2018) Jae‑Rim Heo et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21
- (2018) Bin Yan et al. Oxidative Medicine and Cellular Longevity
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
- (2018) Noomi Vainer et al. Oncotarget
- Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
- (2018) Wamidh H. Talib et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
- (2018) Zhicheng Zeng et al. Nature Communications
- IL-6 roles – Molecular pathway and clinical implication in pancreatic cancer – A systemic review
- (2017) Vlad-Vasile Pop et al. IMMUNOLOGY LETTERS
- Distribution of trans -resveratrol and its metabolites after acute or sustained administration in mouse heart, brain, and liver
- (2017) Marie-Claude Menet et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Consumption of garlic and lemon aqueous extracts combination reduces tumor burden by angiogenesis inhibition, apoptosis induction, and immune system modulation
- (2017) Wamidh H. Talib NUTRITION
- Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells
- (2016) Yoon-Jin Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction
- (2016) Claudine Manach et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages
- (2016) Yoshiyuki Kimura et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Resveratrol intake enhances indoleamine-2,3-dioxygenase activity in humans
- (2016) Guido A. Gualdoni et al. Pharmacological Reports
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer
- (2016) Randall F Holcombe et al. Cancer Management and Research
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- Resveratrol and cancer: Challenges for clinical translation
- (2015) Chandra K. Singh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
- (2015) Zesi Lin et al. BMC Complementary and Alternative Medicine
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer
- (2015) Phuong T. Huynh et al. INTERNATIONAL JOURNAL OF CANCER
- Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
- (2015) J. Gambini et al. Oxidative Medicine and Cellular Longevity
- A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination
- (2015) Channing J. Paller et al. PROSTATE
- Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
- (2015) Thomas Nordstrøm Kjaer et al. PROSTATE
- Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
- (2015) Hong Cai et al. Science Translational Medicine
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Designing a broad-spectrum integrative approach for cancer prevention and treatment
- (2015) Keith I. Block et al. SEMINARS IN CANCER BIOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers
- (2015) CHRISTAKIS SERGIDES et al. Experimental and Therapeutic Medicine
- Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells
- (2015) HYEMIN SEONG et al. Molecular Medicine Reports
- Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells
- (2014) Mee-Hyun Lee et al. Biomolecules & Therapeutics
- Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation
- (2014) Emma L. Wightman et al. BRITISH JOURNAL OF NUTRITION
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Qing-Min Fan et al. CANCER LETTERS
- Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
- (2014) Soo Kyung Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones
- (2014) H-H Sherry Chow et al. Journal of Translational Medicine
- The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
- (2014) Sang Yun Ha et al. PLoS One
- The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver
- (2014) Mei Zhang et al. PLoS One
- Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells
- (2014) X Zhou et al. Cell Death & Disease
- In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
- (2013) Lisa M Bode et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
- (2013) Kyung Tae Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage
- (2013) Hongmei Luo et al. PLoS One
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
- (2013) Maria L. Wikberg et al. TUMOR BIOLOGY
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
- (2012) M. A. Swartz et al. CANCER RESEARCH
- Cellular Constituents of Immune Escape within the Tumor Microenvironment
- (2012) S. P. Kerkar et al. CANCER RESEARCH
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Targeting the Tumor Microenvironment for Cancer Therapy
- (2012) N. E. Sounni et al. CLINICAL CHEMISTRY
- Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells
- (2012) Carolina Emilia Storniolo et al. FOOD CHEMISTRY
- Distribution of Resveratrol Metabolites in Liver, Adipose Tissue, and Skeletal Muscle in Rats Fed Different Doses of This Polyphenol
- (2012) Cristina Andres-Lacueva et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes
- (2012) Arrate Lasa et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast Cancer
- (2012) Weizhu Zhu et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer
- (2012) S Ha et al. ONCOGENE
- High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients
- (2012) Raul Zamora-Ros et al. PHARMACOLOGICAL RESEARCH
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Resveratrol: French Paradox Revisited
- (2012) Betul Catalgol et al. Frontiers in Pharmacology
- Resveratrol in cancer management: where are we and where we go from here?
- (2011) Mary Ndiaye et al. Annals of the New York Academy of Sciences
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Transport, stability, and biological activity of resveratrol
- (2011) Dominique Delmas et al. Annals of the New York Academy of Sciences
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity
- (2011) W.D. Johnson et al. FOOD AND CHEMICAL TOXICOLOGY
- Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
- (2010) Valerie Trapp et al. ANGIOGENESIS
- Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
- (2010) H.-H. S. Chow et al. Cancer Prevention Research
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
- (2010) Paul A. Kroon et al. CURRENT MEDICINAL CHEMISTRY
- Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
- (2010) Juma Hoshino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells
- (2010) H.G. van der Poel et al. UROLOGIA INTERNATIONALIS
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
- (2009) J. Y. Chun et al. CLINICAL CANCER RESEARCH
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
- (2009) Sherryline Jogie-Brahim et al. ENDOCRINE REVIEWS
- Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids
- (2009) Weizhu Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
- (2009) Luis Almeida et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Antitumor Activity of Resveratrol and its Sulfated Metabolites against Human Breast Cancer Cells
- (2009) Michaela Miksits et al. PLANTA MEDICA
- Multi-targeted therapy of cancer by genistein
- (2008) Sanjeev Banerjee et al. CANCER LETTERS
- Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
- (2008) Ilaria Marigo et al. IMMUNOLOGICAL REVIEWS
- The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
- (2008) Marina Zemskova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantification of free and protein-boundtrans-resveratrol metabolites and identification oftrans-resveratrol-C/O-conjugated diglucuronides – Two novel resveratrol metabolites in human plasma
- (2008) Alexander Burkon et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started